Cambridge
United Kingdom
28
2014-11-13
The entities that hold a legal rights for patent applications filed by inventor Grainger David J.:
David J. Grainger from Cambridge, GB has applied for patents for these inventions. The list has both pending applications and granted patents:
3-AMINO LACTAMS AS ANTI-INFLAMMATORY AGENTS
#2 | 2013-07-04Alpha-AminoCycloLactam Ligands for G-Protein Coupled Receptors, and Methods of Using Same
#3 | 2012-04-26TGF-Beta Stimulating Agent Compositions and Combinations
#4 | 2012-03-15Compounds to inhibit or augment an inflammatory response
#5 | 2012-02-23Ligand libraries for screening GPCRs
#6 | 2011-11-24α-aminocyclolactam ligands for G-protein coupled receptors, and methods of using same
#7 | 2011-01-06Anti-inflammatory agents
#8 | 2010-11-183-aminocaprolactam compounds for treating inflammatory disorders
#9 | 2010-05-06Methods of using anti-inflammatory compounds
#10 | 2010-04-22TGF-BETA STIMULANT AND FURTHER AGENT TO REDUCE SIDE EFFECTS
#11 | 2010-01-21Anti-inflammatory agents
#12 | 2009-09-03ApoE mimetic agents
#13 | 2009-08-13Anti-Inflammatory Agents
#14 | 2009-03-19METHODS AND MEANS
#15 | 2009-02-05Anti-inflammatory compounds and compositions
#16 | 2008-10-23Ligands for G-Protein Coupled Receptors
#17 | 2008-08-14Anti-inflammatory agents
#18 | 2008-08-14COMPOSITIONS AND COMBINATIONS 2
#19 | 2008-07-03α-aminocyclolactam ligands for G-protein coupled receptors
#20 | 2008-03-27Anti-inflammatory A-aminocyclolactam compounds
#21 | 2008-02-21Methods to inhibit or augment an inflammatory response
#22 | 2007-07-03Compounds and methods to inhibit or augment an inflammatory response
#23 | 2006-08-22Method to determine TGF-beta
#24 | 2006-06-22Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
#25 | 2006-04-20Compounds and therapies for the prevention of vascular and non-vascular pathologies
#26 | 2006-04-06Compounds and methods to inhibit or augment an inflammatory response
#27 | 2006-02-09Prevention and treatment of cardiovascular pathologies
#28 | 2005-01-27Compounds and therapies for the prevention of vascular and non-vascular pathologies
325521 ⎘